• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Survey: Hospitals skeptical of health reform, ACOs

Article

Survey taker says payers are the only winners in healthcare reform; calls ACO member rules silly.

More than three-fourths of hospital executives responding to a national survey say healthcare reform will decrease their private payer rates, and more than half have no accountable care organization (ACO) strategy or plans.

“As far as health reform, hospitals are skeptical because it's clear that the only certain winner is the payer,” says Brandon Edwards, president of ReviveHealth, the communication firm that conducted the National Payor Survey. “Hospitals are getting hammered with cost pressures, declining volumes, rate pressures, and tighter credit markets. They are fixed asset executives living in a world that’s becoming service economy based. The real problem is that payers are enjoying record profits, with a shrinking base of commercial lives, and the providers are struggling. Health reform is just an added layer of complexity, difficulty, and uncertainty on top of a tough economy and an even tougher operating environment.”

He also cites “the complexity of the arrangements required, the costs, and the silly and counterintuitive rules for assigning and managing members” as reasons why more providers aren’t planning to adopt ACOs.

The survey, which also asks respondents to rank health plans according to a number of factors, ranked WellPoint the worst overall, and BlueCross plans the worst on payment rates for healthcare delivered.

Edwards has some advice for payers.

“First, stop playing games - direct network staff to tell their providers the truth, deal with them honestly, and address issues promptly when they arise. Honesty and transparency goes a long way, even when the payer is telling the provider something they don’t want to hear. Second, payers can look for ways to truly partner with providers. That means being at risk and sharing rewards fairly, rather than shifting risk to members and providers and guaranteeing their own margin before putting anything at risk. There are many other things, but this would be a pretty good start.”

Go back to the Managed Healthcare Executive eNews newsletter.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
© 2024 MJH Life Sciences

All rights reserved.